Targeting protein kinase C and "non-kinase" phorbol ester receptors: Emerging concepts and therapeutic implications

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1754, Issue 1-2, 2005, Pages 296-304

  Kazanietz, Marcelo G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bryostatin; C1 domain; Chimaerin; Diacylglycerol; Phorbol ester; PKC

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 3 [8 [(DIMETHYLAMINO)METHYL] 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL] 4 (1 METHYL 1H INDOL 3 YL) 1H PYRROLE 2,5 DIONE; ACTIN; CALPHOSTIN C; CHIMERIN; CYCLINE; DIACYLGLYCEROL; ISOENZYME; LIPID; PHORBOL ESTER DERIVATIVE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RAC PROTEIN; RECEPTOR; ROTTLERIN;

APOPTOSIS; BINDING AFFINITY; CANCER; CELL CYCLE REGULATION; CONFERENCE PAPER; CYTOSKELETON; DRUG MECHANISM; ENZYME ACTIVATION; MITOGENESIS; MOLECULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL CYCLE; CHIMERIN PROTEINS; DIACYLGLYCEROL KINASE; DIGLYCERIDES; HUMANS; ISOENZYMES; MODELS, BIOLOGICAL; PHORBOL ESTERS; PROTEIN BINDING; PROTEIN KINASE C; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, DRUG; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 29144529161     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2005.07.034     Document Type: Conference Paper

References (71)

1. A.C. Newton The ins and outs of protein kinase C Methods Mol. Biol. 233 2003 3 7
2. H. Mellor, and P.J. Parker The extended protein kinase C superfamily Biochem. J. 332 1998 281 292
3. C. Yang, and M.G. Kazanietz Divergence and complexities in DAG signaling: looking beyond PKC Trends Pharmacol. Sci. 24 2003 602 608
4. A.C. Newton Diacylglycerol's affair with protein kinase C turns 25 Trends Pharmacol. Sci. 25 2004 175 177
5. M.G. Kazanietz, and P.S. Lorenzo Phorbol esters as probes for the study of protein kinase C function Methods Mol. Biol. 233 2003 423 439
6. H. Hennings, P.M. Blumberg, G.R. Pettit, C.L. Herald, R. Shores, and S.H. Yuspa Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin Carcinogenesis 8 1987 1343 1346
7. Z. Szallasi, L. Krsmanovic, and P.M. Blumberg Nonpromoting 12-deoxyphorbol 13-esters inhibit phorbol 12-myristate 13-acetate induced tumor promotion in CD-1 mouse skin Cancer Res. 53 1993 2507 2512
8. M.G. Kazanietz, L.B. Areces, A. Bahador, H. Mischak, J. Goodnight, J.F. Mushinski, and P.M. Blumberg Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes Mol. Pharmacol. 44 1993 298 307
9. P.M. Blumberg, G.R. Pettit, B.S. Warren, A. Szallasi, L.D. Schuman, N.A. Sharkey, H. Nakakuma, M.L. Dell'Aquila, and D.J. de Vries The protein kinase C pathway in tumor promotion Progr. Clin. Biol. Res. 298 1989 201 212
10. B. Konig, P.A. Di Nitto, and P.M. Blumberg Phospholipid and Ca++ dependency of phorbol ester receptors J. Cell. Biochem. 27 1985 255 265
11. J.A. Le Good, W.H. Ziegler, D.B. Parekh, D.R. Alessi, P. Cohen, and P.J. Parker Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1 Science 281 1998 2042 2045
12. P.J. Parker, and J. Murray-Rust PKC at a glance J. Cell Sci. 117 2004 131 132
13. A.C. Newton Regulation of protein kinase C Curr. Opin. Cell Biol. 9 1997 161 167
14. K. Bogi, P.S. Lorenzo, Z. Szallasi, P. Acs, G.S. Wagner, and P.M. Blumberg Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of protein kinase Cdelta: possible correlation with tumor-promoting activity Cancer Res. 58 1998 1423 1428
15. J.D. Black Protein kinase C-mediated regulation of the cell cycle Front. Biosci. 5 2000 D406 D423
16. M.V. Gavrielides, A.F. Frijhoff, C.J. Conti, and M.G. Kazanietz Protein kinase C and prostate carcinogenesis: targeting the cell cycle and apoptotic mechanisms Curr. Drug Targets 5 2004 431 443
17. E. Livneh, and D.D. Fishman Linking protein kinase C to cell-cycle control Eur. J. Biochem. 248 1997 1 9
18. M. Nakagawa, J.L. Oliva, D. Kothapalli, A. Fournier, R.K. Assoian, and M.G. Kazanietz Phorbol ester induced G1 phase arrest selectively mediated by a PKCdelta-dependent induction of p21 J. Biol. Chem. 2005 (in press)
19. H. Mischak, J.A. Goodnight, W. Kolch, G. Martiny-Baron, C. Schaechtle, M.G. Kazanietz, P.M. Blumberg, J.H. Pierce, and J.F. Mushinski Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity J. Biol. Chem. 268 1993 6090 6096
20. P.J. Reddig, N.E. Dreckschmidt, H. Ahrens, R. Simsiman, C.P. Tseng, J. Zou, T.D. Oberley, and A.K. Verma Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate Cancer Res. 59 1999 5710 5718
21. P.J. Reddig, N.E. Dreckschmidt, J. Zou, S.E. Bourguignon, T.D. Oberley, and A.K. Verma Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion Cancer Res. 60 2000 595 602
22. N.R. Murray, L.A. Davidson, R.S. Chapkin, W. Clay Gustafson, D.G. Schattenberg, and A.P. Fields Overexpression of protein kinase C betaII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis J. Cell Biol. 145 1999 699 711
23. J.A. Clark, A.R. Black, O.V. Leontieva, M.R. Frey, M.A. Pysz, L. Kunneva, A. Woloszynska-Read, D. Roy, and J.D. Black Involvement of the ERK signaling cascade in protein kinase C-mediated cell cycle arrest in intestinal epithelial cells J. Biol. Chem. 279 2004 9233 9247
24. L. Li, P.S. Lorenzo, K. Bogi, P.M. Blumberg, and S.H. Yuspa Protein kinase Cdelta targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector Mol. Cell. Biol. 19 1999 8547 8558
25. A. Basu, M.D. Woolard, and C.L. Johnson Involvement of protein kinase C-delta in DNA damage-induced apoptosis Cell Death Differ. 8 2001 899 908
26. M.F. Denning, Y. Wang, S. Tibudan, S. Alkan, B.J. Nickoloff, and J.Z. Qin Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase C Cell Death Differ. 9 2002 40 52
27. T. Ghayur, M. Hugunin, R.V. Talanian, S. Ratnofsky, C. Quinlan, Y. Emoto, P. Pandey, R. Datta, Y. Huang, S. Kharbanda, H. Allen, R. Kamen, W. Wong, and D. Kufe Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis J. Exp. Med. 184 1996 2399 2404
28. C. Brodie, and P.M. Blumberg Regulation of cell apoptosis by protein kinase C delta Apoptosis 8 2003 19 27
29. M. Garzotto, M. White-Jones, Y. Jiang, D. Ehleiter, W.C. Liao, A. Haimovitz-Friedman, Z. Fuks, and R. Kolesnick 12-O-tetradecanoylphorbol-13- acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase Cancer Res. 58 1998 2260 2264
30. C.T. Powell, N.J. Brittis, D. Stec, H. Hug, W.D. Heston, and W.R. Fair Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells Cell Growth Differ. 7 1996 419 428
31. X. Zhao, and M.L. Day RB activation and repression of C-MYC transcription precede apoptosis of human prostate epithelial cells Urology 57 2001 860 865
32. T. Fujii, M.L. Garcia-Bermejo, J.L. Bernabo, J. Caamano, M. Ohba, T. Kuroki, L. Li, S.H. Yuspa, and M.G. Kazanietz Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta J. Biol. Chem. 275 2000 7574 7582
33. M.L. Garcia-Bermejo, F.C. Leskow, T. Fujii, Q. Wang, P.M. Blumberg, M. Ohba, T. Kuroki, K.C. Han, J. Lee, V.E. Marquez, and M.G. Kazanietz Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCalpha.[erratum appears in J Biol. Chem. 2004 May 28;279(22):23846] J. Biol. Chem. 277 2002 645 655
34. Y. Tanaka, M.V. Gavrielides, Y. Mitsuuchi, T. Fujii, and M.G. Kazanietz Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway J. Biol. Chem. 278 2003 33753 33762
35. D. Wu, T.L. Foreman, C.W. Gregory, M.A. McJilton, G.G. Wescott, O.H. Ford, R.F. Alvey, J.L. Mohler, and D.M. Terrian Protein kinase cepsilon has the potential to advance the recurrence of human prostate cancer Cancer Res. 62 2002 2423 2429
36. M.A. McJilton, C. Van Sikes, G.G. Wescott, D. Wu, T.L. Foreman, C.W. Gregory, D.A. Weidner, O. Harris Ford, A. Morgan Lasater, J.L. Mohler, and D.M. Terrian Protein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells Oncogene 22 2003 7958 7968
37. L. Yin, N. Bennani-Baiti, and C.T. Powell Phorbol ester-induced apoptosis of C4-2 cells requires both a unique and a redundant protein kinase C signaling pathway J. Biol. Chem. 280 2005 5533 5541
38. M.G. Kazanietz Novel "nonkinase" phorbol ester receptors: the C1 domain connection. [erratum appears in Mol. Pharmacol. 2002 May; 61(5):1265] Mol. Pharmacol. 61 2002 759 767
39. M.G. Kazanietz, S. Wang, G.W. Milne, N.E. Lewin, H.L. Liu, and P.M. Blumberg Residues in the second cysteine-rich region of protein kinase C delta relevant to phorbol ester binding as revealed by site-directed mutagenesis J. Biol. Chem. 270 1995 21852 21859
40. G. Zhang, M.G. Kazanietz, P.M. Blumberg, and J.H. Hurley Crystal structure of the cys2 activator-binding domain of protein kinase C delta in complex with phorbol este Cell 81 1995 917 924
41. W. Cho Membrane targeting by C1 and C2 domains J. Biol. Chem. 276 2001 32407 32410
42. R.V. Stahelin, M.A. Digman, M. Medkova, B. Ananthanarayanan, J.D. Rafter, H.R. Melowic, and W. Cho Mechanism of diacylglycerol-induced membrane targeting and activation of protein kinase Cdelta J. Biol. Chem. 279 2004 29501 29512
43. J. Giorgione, M. Hysell, D.F. Harvey, and A.C. Newton Contribution of the C1A and C1B domains to the membrane interaction of protein kinase C Biochemistry 42 2003 11194 11202
44. C. Hall, C. Monfries, P. Smith, H.H. Lim, R. Kozma, S. Ahmed, V. Vanniasingham, T. Leung, and L. Lim Novel human brain cDNA encoding a 34,000 Mr protein n-chimaerin, related to both the regulatory domain of protein kinase C and BCR, the product of the breakpoint cluster region gene J. Mol. Biol. 211 1990 11 16
45. N. Brose, and C. Rosenmund Move over protein kinase C, you've got company: alternative cellular effectors of diacylglycerol and phorbol esters J. Cell Sci. 115 2002 4399 4411
46. M.G. Kazanietz Eyes wide shut: protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters Mol. Carcinog. 28 2000 5 11
47. C. Hall, W.C. Sin, M. Teo, G.J. Michael, P. Smith, J.M. Dong, H.H. Lim, E. Manser, N.K. Spurr, T.A. Jones, and L. Lim Alpha 2-chimerin, an SH2-containing GTPase-activating protein for the ras-related protein p21rac derived by alternate splicing of the human n-chimerin gene, is selectively expressed in brain regions and testes Mol. Cell. Biol. 13 1993 4986 4998
48. T. Leung, B.E. How, E. Manser, and L. Lim Germ cell beta-chimaerin, a new GTPase-activating protein for p21rac, is specifically expressed during the acrosomal assembly stage in rat testis J. Biol. Chem. 268 1993 3813 3816
49. T. Leung, B.E. How, E. Manser, and L. Lim Cerebellar beta 2-chimaerin, a GTPase-activating protein for p21 ras-related rac is specifically expressed in granule cells and has a unique N-terminal SH2 domain J. Biol. Chem. 269 1994 12888 12892
50. D. Diekmann, S. Brill, M.D. Garrett, N. Totty, J. Hsuan, C. Monfries, C. Hall, L. Lim, and A. Hall Bcr encodes a GTPase-activating protein for p21rac Nature 351 1991 400 402
51. S. Ahmed, J. Lee, R. Kozma, A. Best, C. Monfries, and L. Lim A novel functional target for tumor-promoting phorbol esters and lysophosphatidic acid. The p21rac-GTPase activating protein n-chimaerin J. Biol. Chem. 268 1993 10709 10712
52. S. Ahmed, J. Lee, L.P. Wen, Z. Zhao, J. Ho, A. Best, R. Kozma, and L. Lim Breakpoint cluster region gene product-related domain of n-chimaerin. Discrimination between Rac-binding and GTPase-activating residues by mutational analysis J. Biol. Chem. 269 1994 17642 17648
53. M.J. Caloca, H. Wang, and M.G. Kazanietz Characterization of the Rac-GAP (Rac-GTPase-activating protein) activity of beta2-chimaerin, a 'non-protein kinase C' phorbol ester receptor Biochem. J. 375 2003 313 321
54. M.J. Caloca, N. Fernandez, N.E. Lewin, D. Ching, R. Modali, P.M. Blumberg, and M.G. Kazanietz Beta2-chimaerin is a high affinity receptor for the phorbol ester tumor promoters J. Biol. Chem. 272 1997 26488 26496
55. M.J. Caloca, H. Wang, A. Delemos, S. Wang, and M.G. Kazanietz Phorbol esters and related analogs regulate the subcellular localization of beta 2-chimaerin, a non-protein kinase C phorbol ester receptor J. Biol. Chem. 276 2001 18303 18312
56. H. Wang, and M.G. Kazanietz Chimaerins, novel non-protein kinase C phorbol ester receptors, associate with Tmp21-I (p23): evidence for a novel anchoring mechanism involving the chimaerin C1 domain J. Biol. Chem. 277 2002 4541 4550
57. M.J. Caloca, M.L. Garcia-Bermejo, P.M. Blumberg, N.E. Lewin, E. Kremmer, H. Mischak, S. Wang, K. Nacro, B. Bienfait, V.E. Marquez, and M.G. Kazanietz beta2-chimaerin is a novel target for diacylglycerol: binding properties and changes in subcellular localization mediated by ligand binding to its C1 domain Proc. Natl. Acad. Sci. U. S. A. 96 1999 11854 11859
58. B. Canagarajah, F.C. Leskow, J.Y. Ho, H. Mischak, L.F. Saidi, M.G. Kazanietz, and J.H. Hurley Structural mechanism for lipid activation of the Rac-specific GAP, beta2-chimaerin Cell 119 2004 407 418
59. P.L. Menna, G. Skilton, F.C. Leskow, D.F. Alonso, D.E. Gomez, and M.G. Kazanietz Role of beta2-chimaerin in the behaviour of murine mammary carcinoma cells in response to extracellular matrix components Cancer Res. 63 2003 2284 2291
60. C. Yang, Y. Liu, F. Coluccio Leskow, V.M. Weaver, and M.G. Kazanietz Rac-GAP-dependent inhibition of breast cancer cell proliferation by beta2-chimerin J. Biol. Chem. 280 2005 24363 24370
61. S. Yuan, D.W. Miller, G.H. Barnett, J.F. Hahn, and B.R. Williams Identification and characterization of human beta 2-chimaerin: association with malignant transformation in astrocytoma Cancer Res. 55 1995 3456 3461
62. O.P. Barry, and M.G. Kazanietz Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy Curr. Pharm. Des. 7 2001 1725 1744
63. B.T. Susarla, and M.B. Robinson Rottlerin, an inhibitor of protein kinase Cdelta (PKCdelta), inhibits astrocytic glutamate transport activity and reduces GLAST immunoreactivity by a mechanism that appears to be PKCdelta-independent J. Neurochem. 86 2003 635 645
64. D.M. Tillman, K. Izeradjene, K.S. Szucs, L. Douglas, and J.A. Houghton Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C Cancer Res. 63 2003 5118 5125
65. D. Yu, M.G. Kazanietz, R.G. Harvey, and T.M. Penning Polycyclic aromatic hydrocarbon o-quinones inhibit the activity of the catalytic fragment of protein kinase C Biochemistry 41 2002 11888 11894
66. L.B. Areces, M.G. Kazanietz, and P.M. Blumberg Close similarity of baculovirus-expressed n-chimaerin and protein kinase C alpha as phorbol ester receptors J. Biol. Chem. 269 1994 19553 19558
67. D. Schechtman, and D. Mochly-Rosen Adaptor proteins in protein kinase C-mediated signal transduction Methods Enzymol. 345 2002 470 489
68. P.S. Lorenzo, J.W. Kung, D.A. Bottorff, S.H. Garfield, J.C. Stone, and P.M. Blumberg Phorbol esters modulate the Ras exchange factor RasGRP3 Cancer Res. 61 2001 943 949
69. R.A. Rambaratsingh, J.C. Stone, P.M. Blumberg, and P.S. Lorenzo RasGRP1 represents a novel non-protein kinase C phorbol ester signaling pathway in mouse epidermal keratinocytes J. Biol. Chem. 278 2003 52792 527801
70. P.S. Lorenzo, M. Beheshti, G.R. Pettit, J.C. Stone, and P.M. Blumberg The guanine nucleotide exchange factor RasGRP is a high-affinity target for diacylglycerol and phorbol esters Mol. Pharmacol. 57 2000 840 846
71. Z.T. Han, X.X. Zhu, R.Y. Yang, J.Z. Sun, G.F. Tian, X.J. Liu, G.S. Cao, H.L. Newmark, A.H. Conney, and R.L. Chang Effect of intravenous infusions of 12-O-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukemia: preliminary studies on therapeutic efficacy and toxicity Proc. Natl. Acad. Sci. U. S. A. 95 1998 5357 5361